Journal of Gynecologic Oncology

Article	Citations
Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity	163
Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled study	50
Nomogram for predicting pathology upstaging in patients with EIN: is sentinel lymph node assessment useful in these patients?	46
Missing a chance to prevent: disparities in completion of genetic evaluation in high-risk patients with endometrial cancer	44
Increased cardiovascular disease risk among adolescent and young adult survivors of cervical cancer	41
Laparoscopic radical hysterectomy without uterine manipulator or vaginal tube use	38
The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial	37
Pregnancy complications and outcomes in patients with early endometrial cancer or atypical hyperplasia after fertility-sparing treatment	30
Para-aortic lymph node dissection with or without nerve-sparing in gynecological malignancies	29
Developing standardized informed consent for hysterectomy and vulva cancer surgery	29
Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JSGO-JSOG joint study	27
Prognostic influence of an early time to chemotherapy following primary cytoreductive surgery for advanced epithelial ovarian cancer	26
Practice guideline for management of endometrial cancer in Thailand: a Thai Gynecologic Cancer Society consensus statement	26
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and over	25
Fertility-sparing treatment outcomes using immune checkpoint inhibitors in endometrial cancer patients with Lynch syndrome	24
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey	24
Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis	22
Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective,	22
Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy	21
Functions, interactions and prognostic role of POLE: a bioinformatics analysis	20
The 7th Biennial Meeting of the Asian Society of Gynecologic Oncology, November 25th to 27th, 2021	19
Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data	19
Is restaging surgery quintessential in suspected early-stage epithelial ovarian cancer? An ancillary study of the Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3002)	18
Evaluation of the role of liver metastasectomy in the treatment of stage IV endometrial cancer	18
Current peritonectomy practice during debulking surgery in patients with newly diagnosed advanced ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 4004)	18

Adjuvant treatment algorithm based on recent ESGO/ESTRO/ESP guidelines for early endometrial carcinoma according to prognostic risk groups	18
Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset	17
Intensified radiochemotherapy with cisplatin and gemcitabine for cervical cancer in the modern era: a retrospective cohort study	17
Salvage hysterectomy for persistent residual cervical cancer: assessment of prognostic factors	16
Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan	16
Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer	16
A step towards the ambition of precision oncology in recurrent ovarian cancer	16
Risk of CIN2+ in women aged >60 years with abnormal cervical cancer screening: a multicenter retrospective cohort study from the Thai Gynecologic Cancer Society research group	16
Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review	16
Prognostic significance of heterologous component in carcinosarcoma of the gynecologic organs: a systematic review and meta-analysis	15
Genotype distribution and risk factors for human papillomavirus infection	14
Supragastric lesser sac: an insidious site for surgical exploration during the debulking surgery in advanced ovarian cancer	14
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multice	14
Enrichment for the POLE mutated against p53 wild subtype using clinicopathologic factors and cyclin B1 immunohistochemistry in endometrial cancer	14
RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma	13
Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial)	13
Olaparib plus bevacizumab as a first-line maintenance treatment for patients with advanced ovarian cancer by molecular status: an updated PAOLA-1 based cost-effectiveness analysis	13
Cervical screening among Chinese females in the era of HPV vaccination: a population-based survey on screening uptake and regular screening following an 18-year organized screening program	13
Efficacy and toxicity of PARP inhibitor in elderly patients with homologous recombination-deficient newly diagnosed advanced ovarian cancer: the role of dose modification	13
East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective	13
A multimodal intervention program to improve sexual health and self-perceived quality of life in patients treated for cervical cancer: a randomized prospective study (PROVIDENCE trial)	13
Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer	13
Efficacy and safety of immune checkpoint inhibitors with chemoradiotherapy/chemotherapy in locally advanced cervical cancer patients: asystematic review and single-arm meta-analysis	13
Cost-effectiveness of atezolizumab plus chemotherapy for advanced/recurrent endometrial cancer	12
Diagnostic accuracy and prognostic factors of uterine serous carcinoma in Japanese women: a multi-center study	12
Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system	12
Comparison of oncologic outcome of preoveratively presumed low-risk endometrial cancer patients who underwent only bilateral pelvic sentinel lymph node (SLN) removal and those who underwent pelvic lym	12
Immunotherapy plus chemotherapy in patients with advanced endometrial cancer: a cost-effectiveness analysis	12
Intra- and postoperative complications associated with diaphragmatic surgery for advanced ovarian cancer	12
Emergency craniotomy: a life-saving procedure as part of multi-modal therapy of GTN	12
Implementation rate and related factors of confirmatory tests following an abnormal Pap smear: a nationwide study from the National Health Insurance	11
Humanized patient-derived xenograft mouse model bearing ovarian clear cell carcinoma	11
Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy	11
Development of a prognostic prediction support system for cervical intraepithelial neoplasia using artificial intelligence-based diagnosis	11
Cost-effectiveness analysis of hospital treatment volume and survival outcomes in endometrial cancer in Japan	11
Differentiation of uterine fibroids and sarcomas by MRI and serum LDH levels: a multicenter study of the KAMOGAWA study	11
Adjuvant pelvic radiation versus observation in intermediate-risk early-stage cervical cancer patients following primary radical surgery: a propensity score-adjusted analysis	11
Clinical implications of the superficial uterine vein pattern for the dissection of the anterior layer of the vesicouterine ligament in radical hysterectomy	11
Preoperative serum microRNAs as potential prognostic biomarkers in ovarian clear cell carcinoma	11
Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients	10
Navigating the future of fertility preservation: advanced predictive strategies for treatment outcomes of endometrial atypical hyperplasia and carcinoma	10
Transabdominal cardiophrenic lymph node dissection for cytoreductive surgery in advanced ovarian cancer	10
Identification of the prognostic immune subtype in copy-number high endometrial cancer	10
A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer	10
HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma	10
Incidence and risk factors for the development of cerebral metastasis in cervical cancer patients	10
Adjuvant carboplatin and paclitaxel with “sandwich” method radiotherapy for stage III or IV endometrial cancer: long-term follow-up at a single-institution	10
Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a “real-life setting”	10
The sealing effect of magnetic-sealing uterine manipulator in isolated uterus from patients with early-stage cervical cancer: a pre-clinical study	9
Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia	9

Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups	9
The necessity of adjuvant surgery for patients with high-risk chemorefractory or relapsed gestational choriocarcinoma with complete remission after anti-PD-1 therapy	9
Evolving standards and future directions for systemic therapies in cervical cancer	9
Risk of ovarian cancer in women with pelvic inflammatory disease and homologous recombination repair gene mutations under 55: a population-based cohort study	9
RAIDS atlas of significant genetic and protein biomarkers in cervical cancer	8
Protective ostomies in ovarian cancer surgery: a systematic review and meta-analysis	8
Reviewer recognition in 2024	8
Th2 cells infiltrating high-grade serous ovarian cancer: a feature that may account for the poor prognosis	8
Alternative splicing of PSMD13 mediated by genetic variants is significantly associated with endometrial cancer risk	8
Prognostic value of complete metabolic response on 18F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer	8
Laparoscopy-assisted laterally extended endopelvic resection and sacrectomy (beyond laterally extended endopelvic resection) for platinum-sensitive recurrent ovarian cancer	8
Validation of HPV triage in cytology-based cervical cancer screening for ASC-US cases using Japanese data	8
A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial h	8
LncRNA linc01194 promotes the progress of endometrial carcinoma by up-regulating SOX2 through binding to IGF2BP1	8
Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening	8
Bevacizumab combined with chemotherapy could be superior to chemotherapy alone in relapsed ovarian cancer after PARPi: evidence from a multi-center propensity score-matched analysis	8
Asian Society of Gynecologic Oncology (ASGO) 2024 Annual Meeting in Bali, Indonesia	7
Response to Corcept’s retraction request on manuscript of “Relacorilant plus nab-paclitaxel for recurrent, platinum-resistant ovarian cancer: a cost-effectiveness study”	7
Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer	7
Erratum: The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization	7
The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma	7
Can surgery boost the survival benefit of chemoradiotherapy in T1b1-T2a1 stage cervical cancer with lymph node metastasis? A population-based study	7
Sentinel node mapping in endometrial cancer	7
Subsequent primary cancer incidence in cervical cancer survivors: insights from a comprehensive cohort study utilizing combined Japanese population-based cancer registries	7
The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 2023	7
Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis	7
Platinum free interval and clinical benefit of the second-line chemotherapy in recurrent uterine and ovarian carcinosarcoma: a retrospective cohort analysis	7
Comparison of carboplatin-based chemotherapy versus cisplatin-based chemotherapy in the treatment of malignant gonadal germ cell tumor: a systematic review and meta-analysis	7
Minimally invasive radical hysterectomy and the importance of avoiding cancer cell spillage for early-stage cervical cancer: a narrative review	7
Clinical practice guidelines for cervical cancer: an update of the Korean Society of Gynecologic Oncology Guidelines	7
Cancer-field surgery for endometrial cancer by robotic peritoneal mesometrial resection and targeted compartmental lymphadenectomy (PMMR+TCL)	7
The SHAPE trial: is good is good enough?	7
Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study	6
Bispecific immunotherapy MEDI5752 or volrustomig and cervical cancer	6
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications	6
Mutations in homologous recombination repair genes in patients with metastatic endometrial cancer: association with clinical characteristics and prognosis	6
Targeting BRAF pathway in low-grade serous ovarian cancer	6
The course forward: next generation sequencing as part of the next generation management of patients with locally advanced cervical cancer	6
Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer	6
Improved bladder function in radical hysterectomy without worsening oncologic outcome: resection of the posterior layer of the vesicouterine ligament with the procedure limited to the vesical veins	6
Timing of adjuvant radiotherapy for early-stage endometrial carcinoma: a single-center retrospective cohort study	6
Revisiting the meaning of Trousseau sign and syndrome	6
Rotational intraperitoneal pressurized aerosol chemotherapy with paclitaxel and cisplatin: pharmacokinetics, tissue concentrations, and toxicities in a pig model	6
Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)	6
Prognostic values of tumor size and location in early stage endometrial cancer patients who received radiotherapy	6
Comparison of the safety between cervical conization and hysterectomy for patients with cervical adenocarcinoma in situ	6
TP53 variants in p53 signatures and the clonality of STICs in RRSO samples	6
Incidence and treatment outcomes of uterine cervical cancer in Korea 1999–2018 from the national cancer registry	6
CircSMAD2 accelerates endometrial cancer cell proliferation and metastasis by regulating the miR-1277-5p/MFGE8 axis	6
The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation	6
Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma	6
Effectiveness of craniotomy and long-term survival in 35 patients with gestational trophoblastic neoplasia with brain metastases: a clinical retrospective analysis	6
Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial	6
Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of O	6
Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics	5
Oncologic outcomes according to the level of disease burden in patients with metachronous distant metastases from uterine cervical cancer: a Korean Radiation Oncology Group study (KROG 18-10)	5
Interleukin-34 cancels anti-tumor immunity by PARP inhibitor	5
Gut microbiome associated with PARP inhibitor efficacy in patients with ovarian cancer	5
Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer	5
Efficacy and prognosis of robotic surgery with sentinel node navigation surgery in endometrial cancer	5
Molecular classification of endometrial cancer: entering an era of precision medicine	5
PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia	5
Poor accuracy of endometrial sampling in patients with uterine carcinosarcomas: a nationwide analysis	5
Trends in the cost of ovarian cancer across phases of care and surgical years in Korea	5
Erratum: Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer	5
Postoperative conventional versus hypofractionated intensity-modulated radiation therapy with concurrent chemotherapy in cervical cancer: a prospective multicenter randomized phase III trial (POHIM_P3	5
Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study	5
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Onco	5
Missing a chance to prevent: disparities in completion of genetic evaluation in high-risk patients with endometrial cancer	5
Prognostic factors and optimal management approaches for stage IB uterine leiomyosarcoma: a retrospective analysis	5
Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic	5
Clinical trial comparing the use of Orcellex® Brush versus Cervex-Brush® on vaginal vault smear cytology adequacy rate in patients treated with radiotherapy for cervical cancer	5
Reevaluating the vesicouterine pouch: histological evidence for optimal dissection planes in oncologic surgery	5
Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT)	5
Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study	5
Prognostic factors of dose-response relationship for nodal control in metastatic lymph nodes of cervical cancer patients undergoing definitive radiotherapy with concurrent chemotherapy	5
Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: an	5
Intraoperative frozen pathology exam of Common iliac lymph nodes and Para-Aortic lymphadenectomy on the prognosis and quality of life for patients with IB2-IIA2 Cervical Cancer: trial protocol for a r	5
Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer	5
An overview of the current debate between using minimally invasive surgery versus laparotomy for interval cytoreductive surgery in epithelial ovarian cancer	5

Different surgical methods for FIGO stage IVB cervical cancer patients receiving chemotherapy: a population-based study	5
Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience	5
The activity of immune checkpoint inhibitors in patients with recurrent cervical cancer developed in previously irradiated field: clinical and immunohistochemical investigations	4
HIPEC in recurrent ovarian cancer: flogging a tired HORSE?	4
A predictive model for lymph node metastasis using tumor location in presumed early-stage endometrioid endometrial cancer patients	4
Role of adjuvant chemotherapy in stage IC ovarian granulosa cell tumors: a systematic review and meta-analysis	4
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer	4
Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis	4
ASGO 7th International Workshop on Gynecologic Oncology	4
TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR/ERK pathway	4
Novel vaginoplasty technique involving the use of peritoneal flaps during laparoscopic radical hysterectomy for early-stage cervical cancer	4
Modified posterior pelvic exenteration combined with ileocecal resection for locally advanced endometrial cancer	4
Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al.	4
Circular RNA intraflagellar transport 80 facilitates endometrial cancer progression through modulating miR-545-3p/FAM98A signaling	4
Nodal surgery in early-stage cervical cancer: the PHENIX trial and the road ahead	4
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial	4
FIGO staging of endometrial cancer: 2023	4
Risk factors associated with overall survival in patients with cervical cancer: a prospective cohort study in Western China comparing random survival forest and Cox proportional hazards models	4
HPV vaccination status and effectiveness in Korean women with HPV16/18 infection (2010–2021): a retrospective study	4
Expert commentary on HORSE/MITO18 and CHIPOR	4
International cost-effectiveness analysis of chemoradiotherapy plus pembrolizumab for locally advanced cervical cancer	4
Prognostic factors of adult granulosa cell tumors of the ovary: a Turkish retrospective multicenter study	4
RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study	4
Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis	4
Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan	4
Knowledge and awareness of cervical cancer and prevention measures among female students in Poland: a cross-sectional, decade apart study	4
Predictors of postoperative pancreatic fistula after splenectomy with or without distal pancreatectomy performed as a component of cytoreductive surgery for advanced ovarian cancer	3
Oncogenic pathway landscape of ovarian cancer and correlation with clinical prognosis	3
Diagnostic performances of the Ovarian Adnexal Reporting and Data System, the Risk of Ovarian Malignancy Algorithm, and the Copenhagen Index in the preoperative prediction of ovarian cancer: a prospec	3
Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas	3
Genetic analysis of cervical cancer with lymph node metastasis	3
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study	3
Planning and performing simultaneous bariatric surgery and robotic hysterectomy in a super-obese patient with endometrial cancer	3
Is it time to change surgery for early-stage low-risk cervical cancer to simple hysterectomy?	3
Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCR	3
The prognosis impact of NACT-IDS and PDS in advanced ovarian cancer: a systematic review and meta-analysis	3
Retraction: Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity	3
FUS-stabilized USP7 facilitates the bevacizumab resistance of ovarian cancer through deubiquitinating PTK2	3
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement	3
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent end	3
Revision of quality indicators for cervical cancer and trend analysis of existing indicators in Japan	3
Integrated analysis of DNA methylome and transcriptome reveals SFRP1 and LIPG as potential drivers of ovarian cancer metastasis	3
Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome	3
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer	3
Regularity of cervical cancer screening in Korea: analysis using national public data for 12 years	3
Airborne and surface contamination after rotational intraperitoneal pressurized aerosol chemotherapy using cisplatin	3
SLAMF7 predicts prognosis and correlates with immune infiltration in serous ovarian carcinoma	3
Book Review: IARC handbooks of cancer prevention, volume 18: Cervical cancer screening	3
The prognostic significance of primary tumor site in vulvar cancer: a population-based cohort study	3
Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer	3
Association between resection margin and local recurrence in the treatment of primary squamous cell vulvar carcinoma	3
Where is ERAS in the management of advanced ovarian cancer?: between myths and truths	3
Letter to editor regarding the published manuscript: “A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer”	3
Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting	3
Clinical outcome and pattern of care for isolated or incidental serous tubal intraepithelial carcinoma: a multicenter retrospective cohort study	3
Reviewer recognition in 2022	3
Efficacy of intra-abdominal cytoreductive surgery in advanced endometrial cancer with distant metastasis	3
ATF1 regulates MAL2 expression through inhibition of miR-630 to mediate the EMT process that promotes cervical cancer cell development and metastasis	3
Impact of peritoneal vaginoplasty combined with radical hysterectomy on the quality of sexual life for patients with early-stage cervical cancer: trial protocol for a multi-center superiority randomiz	3
Global burden of uterine cancer in 204 countries and territories and its predicted level in 15 years, from 1990 to 2021	3
Immunonutrition in ovarian cancer: clinical and immunological impact?	3
Evaluating the specific STAT3 inhibitor YHO-1701 in ovarian cancer cell lines and patient-derived cell models: efficacy, mechanisms, and therapeutic potential	3
AP2α negatively regulates PDHA1 in cervical cancer cells to promote aggressive features and aerobic glycolysis in vitro and in vivo	3
Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)	3
Ovarian squamous cell carcinoma: clinicopathological features, prognosis and immunotherapy outcomes	3
Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines	3
Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models	2
Adjuvant chemotherapy after radical hysterectomy yields comparable outcomes to chemoradiation for stage IB2-IIB and IIIC1-2 cervical cancer: a single-center retrospective study	2
Molecular and pathological analysis of FOXL2 and TERT promoter mutations in adult-type granulosa cell tumo	2
Attitudes toward subsequent primary cancer prevention among survivors of childhood, adolescent, and young adult (CAYA) cancer in Japan: results of a comprehensive questionnaire survey on long-term wom	2
Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes	2
Associations between obesity, metabolic syndrome, and endometrial cancer risk in East Asian women	2
Comparison of survival outcomes between robotic and laparoscopic radical hysterectomies for early-stage cervical cancer: a systemic review and meta-analysis	2
Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052)	2
Anticancer effect of the antipsychotic agent penfluridol on epithelial ovarian cancer	2
Exploring willingness to pay out-of-pocket for genetic testing among ovarian cancer patients in Malaysia, a middle-income country in Asia	2
Epidemiologic study on gestational trophoblastic diseases in Japan	2
Diagnostic performance of microRNA-34a, let-7f and microRNA-31 in epithelial ovarian cancer prediction	2
Unveiling pembrolizumab effectiveness in diverse subtypes of MSI-high endometrial cancers	2
Phase II randomized study of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab alone or with nesuparib, in mismatch-repair proficient, adva	2
Improving the efficacy and safety of concurrent chemoradiotherapy by neoadjuvant chemotherapy: a randomized controlled study of locally advanced cervical cancer with a large tumor	2
Comparison of postoperative adjuvant platinum-based chemotherapy and no further therapy after radical surgery in intermediate-risk early-stage cervical cancer	2
Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles	2
Simple hysterectomy SHAPE-ing up to be the treatment of choice for early cervical cancer under 2 cm	2
Author's reply to: Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer	2
Response to: Author's reply to: Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002)	2
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial	2
Effectiveness and safety of nab-paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study	2
A novel non-invasive mRNA-lncRNA biomarker panel for accurate prediction of cervical squamous cell carcinoma and adenocarcinoma	2
Author's reply to: Cisplatin versus carboplatin?	2
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study	2
Number of FoxP3+ regulatory T-cells are associated with recurrence in vulvar squamous cell carcinoma	2
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines	2
Risk factors for lower extremity lymphedema after surgery in cervical and endometrial cancer	2
Early prediction and risk stratification of ovarian cancer based on clinical data using machine learning approaches	2